| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5958ad9a7c392f9b9f2f968c868f56fa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5a05d260411db5deaad8fc25a410f691
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5ef5867c2ce01671926e0b847e8d9147
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1399f984e04977e82e45a94e8f841c9c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1cae3f94f0c4b51cb92bd75919fb4284 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-192
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-192
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377 |
| filingDate |
2013-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2018-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_433991759eabbe3b11e656a2c7cf1d07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d5bf0945980b4b5dd684887658e7ad84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd9a423af925dc09896f0f183dd2177a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3344be949ae4c832609170cb8127e081 |
| publicationDate |
2018-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-9895377-B2 |
| titleOfInvention |
Solid forms of tyrosine kinase inhibitors, process for the preparation and their pharmaceutical composition thereof |
| abstract |
The present invention generally relates to solid forms of tyrosine kinase inhibitors, in particular combinations of tyrosine kinase inhibitors with anti-oxidative acids, processes for its preparation and a pharmaceutical compositions containing the same. |
| priorityDate |
2012-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |